Yuanqing Tan
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Developing standards to support the clinical translation of stem cells.
Journal: Stem cells translational medicine
Published: November 01, 2021
Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.
Journal: Cell proliferation
Published: September 26, 2020
Hyaluronate supports hESC-cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction.
Journal: Cell proliferation
Published: September 23, 2020
First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells.
Journal: Cell proliferation
Published: September 17, 2020
Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.
Journal: Cell proliferation
Published: September 17, 2020
Generation of clinical-grade functional cardiomyocytes from human embryonic stem cells in chemically defined conditions.
Journal: Journal of tissue engineering and regenerative medicine
Published: April 14, 2016
Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Journal: Stem cell research & therapy
Published: March 26, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026